Heron Therapeutics Inc (NASDAQ:HRTX)

31.00
Delayed Data
As of May 23
 -0.60 / -1.90%
Today’s Change
12.70
Today|||52-Week Range
34.00
+71.27%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues0.000.001.3M30.8M
 
 
 
Cost of Goods Sold0.000.0035.0K3.1M
 
 
 
Depreciation And Amortization578.0K734.0K1.1M1.5M
 
 
 
 
 
 
Operating ExpensesGross Income-578.0K-734.0K145.0K26.2M
 
 
 
 
 
General Expenses74.0M96.2M163.3M218.9M
 
 
 
 
 
Research And Development54.8M61.2M96.4M137.1M
 
 
 
 
 
Total Operating Expenses74.6M96.9M164.4M223.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-74.6M-96.9M-163.1M-192.8M
 
 
 
 
 
Extraordinary Charge0.000.00-7.8M-1.8M
 
 
 
Interest Expense On Debt887.0K958.0K2.7M3.9M
 
 
 
 
 
Other Expenses-919.0K292.0K436.0K-38.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-76.4M-97.6M-173.1M-197.5M
 
 
 
 
 
Net Income-76.4M-97.6M-173.1M-197.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS26.6M33.1M37.9M54.0M
 
 
 
 
 
Shares To Calculate EPS Diluted26.6M33.1M37.9M54.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.87-$2.95-$4.56-$3.65
 
 
 
 
 
EPS Diluted-$2.87-$2.95-$4.57-$3.65